Dluhy R G
Brigham & Women's Hospital, Boston, MA 02115, USA.
Respir Med. 1997 Nov;91 Suppl A:32-3. doi: 10.1016/s0954-6111(97)90104-9.
The potency of the inhaled corticosteroid, dose, duration of treatment, and the study subject receiving treatment all play a role in the effects observed on the HPA axis. At low/medium doses of inhaled corticosteroids, where there is minimal/modest HPA axis suppression, there should be no risk of adrenal crisis even under stressful conditions (6). Thus, the risk of acute adrenal insufficiency, culminating in adrenal crisis, in patients taking inhaled steroids is extremely unlikely.
吸入性糖皮质激素的效力、剂量、治疗持续时间以及接受治疗的研究对象,在对下丘脑-垂体-肾上腺(HPA)轴观察到的效应中均发挥作用。在低/中剂量吸入性糖皮质激素的情况下,HPA轴抑制作用最小/适度,即使在应激状态下也不应存在肾上腺危象的风险(6)。因此,吸入性类固醇治疗的患者发生急性肾上腺功能不全并最终导致肾上腺危象的风险极不可能出现。